3D Tissue Models

View Profile

Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors Review type Summary Keywords File filename File mime type
1. 2013 Multicenter Feasibility Study of Combination Therapy with Fluorouracil, Leucovorin and Paclitaxel (FLTAX) for Peritoneal Disseminated Gastric Cancer with Massive Ascites or Inadequate Oral Intake Japanese Journal of Clinical Oncology Epub ahead of print.
2. 2013 Pharmacokinetic parameters from 3-Tesla DCE-MRI as surrogate biomarkers of antitumor effects of bevacizumab plus FOLFIRI in colorectal cancer with liver metastasis. Int J Cancer. Epub ahead of print
3. 2013 A feasibility study of outpatient chemotherapy with S-1 + cisplatin in patients with advanced gastric cancer Gastric Cancer. Epub ahead of print
4. 2012 Phase I study of cediranib in combination with cisplatin plus fluoropyrimidine (S-1 or capecitabine) in Japanese patients with previously untreated advanced gastric cancer Cancer Chemother Pharmacol. 69: 439-446, 2012
5. 2012 First-line fluorouracil-based chemotherapy for patients with severe peritoneal disseminated gastric cancer Gastric Cancer. 15: 21-26, 2012
6. 2012 Nucleostemin and TWIST as predictive markers for recurrence after neoadjuvant chemotherapy for esophageal carcinoma Cancer Sci. 103: 233-238, 2012
7. 2011 Systemic chemotherapy for peritoneal disseminated gastric cancer with inadequate oral intake: a retrospective study. Int J Clin Oncol. 16: 57-62, 2011
8. 2011 Phase II study of bolus 5-fluorouracil and leucovorin combined with weekly paclitaxel as first-line therapy for advanced gastric cancer Oncology. 81: 291-297, 2011
9. 2011 Genetic variation and haplotype structures of the glutathione S-transferase genes, GSTA1 and GSTA2, in Japanese colorectal cancer patients. Drug Metab Pharmacokinet. 26: 646-658, 2011
10. 2011 Characteristics and outcome of patients with advanced gastric cancer who declined to participate in a randomized clinical chemotherapy trial J Oncol Pract. 7: 148-153, 2011
11. 2011 Management of adjuvant S-1 therapy after curative resection of gastric cancer: dose reduction and treatment schedule modification Gastric Cancer. 14: 28-34, 2011
12. 2011 Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma Gastric Cancer. 14: 161-165, 2011
13. 2010 Progression-free survival in first-line chemotherapy is a prognostic factor in second-line chemotherapy in patients with advanced gastric cancer J Cancer Res Clin Oncol 136: 1059-1064, 2010
14. 2010 Phase I study of NK012, a novel SN-38-incorporating micellar nanoparticle, in adult patients with solid tumors Clin Cancer Res 16: 5058-5066, 2010
15. 2010 Sequential chemotherapy with methotrexate and 5-fluorouracil for chemotherapy-naïve advanced gastric cancer with disseminated intravascular coagulation at initial diagnosis J Cancer Res Clin Oncol 136: 243-248, 2010
16. 2010 Genetic polymorphisms of FCGRT encoding FcRn in a Japanese population and their functional analysis. Drug Metab Pharmacokinet 25: 578-587, 2010
17. 2010 Adipocytokines as New Promising Markers of Colorectal Tumors: Adiponectin for Colorectal Adenoma, and Resistin and Visfatin for Colorectal Cancer Cancer Science 101 : 1286-1291, 2010
18. 2010 Plasma concentration of VCAM-1 and PAI-1: A predictive biomarker for post-operative recurrence in colorectal cancer Cancer Science 101: 1886-1890, 2010
19. 2009 Genetic polymorphisms of copper- and platinum drug-efflux transporters ATP7A and ATP7B in Japanese cancer patients Drug Metab Pharmacokinet 24: 565-574, 2009
20. 2009 A Phase I Trial of 5-fluorouracil with Cisplatin and Concurrent Standard-dose Radiotherapy in Japanese Patients with Stage II/III Esophageal Cancer. Japanese Journal of Clinical Oncology 39 (1): 37-42, 2009
21. 2009 Adipocytokine levels in gastric cancer patients – Resistin and visfatin as biomarkers of gastric cancer and its stage progression, and adiponectin as a biomarker of early stage J Gastroenterology 44: 685-690, 2009
22. 2009 Palliative radiation therapy for hemorrhage of unresectable gastric cancer: a single institute experience J Cancer Res Clin Oncol 135: 1117-1123, 2009
23. 2009 Lymoh node staging in esophageal squamous cell carcinoma: A comparative study of endoscopic ultrasonography versus computed tomography J Gastroen Hepatol 24: 1687-1691, 2009
24. 2009 Effects of bavacizumab on plasma concentration of irinotecan and its metabolites in advanced colorectal cancer patients receiving FOLFIRI with bevacizumab as second-line chemotherapy Cancer Chemother Pharmacol 65: 467-471, 2009
25. 2009 Adipocytokines and squamous cell carcinoma of the esophagus J Cancer Res Clin Oncol 136: 261-266, 2009.
26. 2009 Standard First-Line Chemotherapy for Metastatic Gastric Cancer in Japan Has Met the Global Standard: Evidence From Recent Phase III Trials Gastrointest Cancer Res. 3: 239-244, 2009
27. 2008 Clinical Significance of Insulin-Like Growth Factor Receptor in Patients with Advanced Gastric Cancer Oncology 74: 76-83, 2008
28. 2008 Combination chemotherapy with cisplatin and irinotecan in patients with adenocarcinoma of the small intestine Gastric Cancer 11: 201-205, 2008
29. 2008 Antitumor Effect of SN-38-Releasing Polymeric Micelles, NK012, on Spontaneous Peritoneal Metastasis from Orthotopic Gastric Cancer in Mice Compared with Irinotecan Cancer Research 68 (22): 9318-9322, 2008
30. 2008 A Phase I Study of Bolus 5-fluorouracil and Leucovorin Combined with Weekly Paclitaxel (FLTAX) as First-line Therapy for Advanced Gastric Cancer Japanese Journal of Clinical Oncology 38 (8): 540-546, 2008
31. 2008 Chemosensitivity of patients with recurrent esophageal cancer receiving perioperative chemotherapy Diseases of the Esophagus 21 (7): 607-11, 2008
32. 2008 Combination of O6-methylguanine-DNA methyltransferase and thymidylate synthase for the prediction of fluoropyrimidine efficacy European Journal of Cancer 44: 400-407, 2008
33. 2008 Synergistic antitumor activity of the novel SN-38-incorporating polymeric micelles, NK012, combined with 5-fluorouracil in a mouse model of colorectal cancer, as compared with that of irinotecan plus 5-fluorouracil International Journal of Cancer 122: 2148-2153, 2008
34. 2008 Impact of excision repair cross-complementing gene I (ERCC1), dihydropyrimidine degydrogenese, and epidermal growth factor receptor on the outocomes of patients with advanced gastric cancer British Journal of Cancer 98: 832-839, 2008
35. 2007 Distribution and significance of the esophageal and gastric cardiac mucosae: a study of 131 operation specimens Histopathology 51: 515-519, 2007
36. 2006 Metachronous gastric cancers after endoscopic resecton: how effective is annual endoscopic surveillance? Gastric Cancer 9(2): 93-98, 2006
37. 2006 Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: Analysis of 464 surgically resected cases Modern Pathology 19: 475-480, 2006
38. 2003 Is Endoscopic One-piece Mucosal Resection Essential for Early Gastric Cancer ? Digestive Endoscopy 15:113-116, 2003
39. 2001 Hypoglycemia Associated with the Production of Insulin-like Growth Factor â…¡ in Adenocortical Carcinoma Internal Medicine 40:759-763,2001

About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.